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Preoperative Opioid Use Is Associated With Inferior
Patient-Reported Outcomes Measurement
Information System Scores Following Rotator Cuff
Repair
Fabien Meta, M.D., Laﬁ S. Khalil, M.D., Alexander C. Ziedas, B.S., Caleb M. Gulledge, B.S.,
Stephanie J. Muh, M.D., Vasilios Moutzouros, M.D., and Eric C. Makhni, M.D., M.B.A.

Purpose: To determine the inﬂuence of preoperative opioid use on Patient-Reported Outcomes Measurement Information System (PROMIS) scores pre- and postoperatively in patients undergoing arthroscopic rotator cuff repair (RCR).
Methods: A retrospective review of all RCR patients aged >18 years old was performed. PROMIS pain interference
(“PROMIS PI”), upper extremity function (“PROMIS UE”), and depression (“PROMIS D”) scores, were reviewed. These
measures were collected at preoperative, 6-month, and 1-year postoperative time points. A prescription drugemonitoring
program was queried to track opioid prescriptions. Patients were categorized as chronic users, acute users, and nonusers
based on prescriptions ﬁlled. Comparison of means were carried out using analysis of variance and least squares means.
Effect sizes and 95% conﬁdence intervals were calculated. Results: In total, 184 patients who underwent RCR were
included. Preoperatively, nonusers (n ¼ 92) had superior PROMIS UE (30.6 vs 28.9 vs 26.1; P < .05) and PI scores (61.5 vs
64.9 vs 65.3; P < .001) compared with acute users (n ¼ 65) and chronic users (n ¼ 27), respectively. At 6 months
postoperatively; nonusers demonstrated signiﬁcantly greater PROMIS UE (41.7 vs 35.6 vs. 33.5; P < .001), lower PROMIS
D (41.6 vs 45.8 vs 51.1; P < .001), and lower PROMIS PI scores (50.7 vs 56.3 vs 58.1; P < .01) when compared with acute
and chronic users, respectively. Nonusers had lower PROMIS PI (47.9 vs 54.3 vs 57.4; P < .0001) and PROMIS D (41.6 vs
48.3 vs 49.2; P ¼ .0002) scores compared with acute and chronic users at 1-year postoperatively. Nonusers experienced a
signiﬁcantly greater magnitude of improvement in PROMIS D 6 months postoperatively compared with chronic opioid
users (e5.9 vs 0.0; P < .01). Conclusions: Patients undergoing RCR demonstrated superior PROMIS scores pre- and
postoperatively if they did not use opioids within 3 months before surgery. Level of Evidence: III, retrospective
comparative trial.

M

anaging pain is an important dilemma that providers face, as patient-reported pain on a
numeric scale has become a ﬁfth vital sign in patient
care.1 Over the past several decades, Americans have
found themselves in an opioid epidemic, with
increasing rates of opioid prescriptions, overdose, and
accidental death secondary to overdose.2,3 Nevertheless, opioids are an important aspect to postoperative

pain management following musculoskeletal surgery,
leaving orthopaedic surgeons responsible for a large
number of nationwide prescriptions, which has caught
the attention of government legislastion.4,5 With
increasing rates of orthopaedic surgeries performed,
orthopaedic surgeons have a unique opportunity to
ﬁnd alternative regimens and reducing the societal
impact of opioid prescriptions.6-12 This must strike a
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delicate balance with maintaining patient satisfaction
following surgery, however, which has been shown to
be intricately related to pain control.7,13-16
Pain control, through means of opioid consumption,
also has been shown to directly affect patient outcomes
following elective procedures in a dose-dependent
manner,17,18 with preoperative opioid use correlating
to poor outcomes following elective spine, arthroplasty,
and sports medicine orthopaedic surgeries.19-24 Traditionally, surgical outcomes were assessed using a variety of patient-reported outcome measures that were
restricted to certain patient populations and conditions
to evaluate the response to speciﬁc interventions,
limiting the ability of providers to compare these tools
in a standardized fashion.25-28 The Patient-Reported
Outcomes
Measurement
Information
System
(PROMIS) is a contemporary platform using computerized adaptive testing (CAT) to collect patient outcomes, creating a uniform and standardizable metric. A
number of these domains, such as physical function,
mental health, and interference of function due to pain,
are important predictors of patient outcomes.29-31 This
exciting development has enabled standardized comparisons across patient populations and surgical interventions to evaluate the impact of preoperative
patient characteristics on postoperative surgical outcomes using PROMIS scales.31-37
Despite several investigations, which have validated
the use of PROMIS in patients with shoulder pathology,
there remains a paucity of literature examining the
impact of preoperative opioid use on postoperative outcomes as assessed by PROMIS outcome measures.36-40
Rotator cuff tears (RCTs) and subsequent recovery
following rotator cuff repair (RCR) can cause signiﬁcant
pain, which traditionally have been treated with strong
analgesics in the preoperative and immediate postoperative periods.41-44 Beyond pain and function, there
is also a signiﬁcant relationship between anxiety/
depression and rotator cuff repair outcomes.45-47 However, the relationship of opioid analgesics on pain,
function, and mood as measured by PROMIS scores in
patients undergoing RCRs is yet to be well-deﬁned.
Although previous studies illustrate greater opioid use
in patients with comorbid depression/anxiety who undergo RCR, there is a paucity of literature that examines
the relationship of opioid use to mood scores in a quantitative manner.48 The purpose of this study is to determine the inﬂuence of preoperative opioid use on
PROMIS scores pre- and postoperatively in patients undergoing arthroscopic RCR. It was hypothesized that
patients who are taking opioids before RCR would have
worse postoperative patient-reported outcomes.

Methods

A retrospective review of patients aged >18 years of
age with symptomatic RCT was completed. In this

institutional review board-approved study (#14235;
Henry Ford Hospital), patients who underwent primary
arthroscopic RCR performed by 1 of 3 fellowship
trained orthopaedic surgeons, afﬁliated with a single
integrated health system, were included in this study.
Patients with concomitant fractures, labral pathology,
previous shoulder surgery, isolated subacromial
decompression, unable or unwilling to complete
PROMIS questionnaires, and records not retrievable
from the statewide prescription drugemonitoring program (PDMP) were excluded. Once these patients were
identiﬁed, date of surgery, date of preoperative
PROMIS CAT form completion, date of postoperative
PROMIS CAT form completion, and respective PROMIS
PI, PROMIS UE, and PROMIS D scores were recorded.
In addition, demographic data, including sex, age, race,
ethnicity, body mass index, zip code, and smoking
status were retrospectively collected from each patient’s
electronic medical record.
Preoperative narcotic use was conﬁrmed by reviewing
patient opioid prescription records within the statewide
PDMP. This program veriﬁes each prescription that was
ﬁlled by the patient at a pharmacy, thereby serving as a
more accurate surrogate of opioid use than previous
studies based off prescriptions in the electronic medical
record.19,20 Patients were categorized based on their
opioid prescriptioneﬁlling practices before surgery.19,49
Chronic users were deﬁned as patients who had opioid
prescriptions ﬁlled for greater than 30 days during the
3-month period before surgery (n ¼ 27). Acute users
were deﬁned as patients who had a single opioid prescription ﬁlled within the 3 months before surgery, but
not for a duration of greater than 30 consecutive days
(n ¼ 65). Finally, a nonuser was deﬁned as a patient
without any opioid prescription within the 3 months
before surgery (n ¼ 92). Additional data, including the
quantity prescribed in the 3-month preoperative
period, total number of days with an opioid prescription
in the 3-month preoperative period, average daily dose
measured in morphine milligram equivalents (MMEs),
number of opioid prescriptions in the 3-month preoperative period, number of opioid prescriptions in the 1month preoperative period, number of prescribers in
the 3-month preoperative period, and number of prescribers in the 1-month preoperative period were also
collected for each patient using the PDMP.
The Research Electronic Data Capture (REDCap)
platform, a secure, web-based application system, was
used to prospectively collect patient-reported outcomes.50 Patient-reported outcomes were measured
using PROMIS CAT forms, which were completed by
patients undergoing RCR on a tablet computer during
each preoperative and postoperative ofﬁce visit.
PROMIS pain interference (PROMIS PI), physical
function upper extremity (PROMIS UE), and depression (PROMIS D) scores were collected during the
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PREOPERATIVE OPIOID USE AFFECTS RCR OUTCOMES
Table 1. Demographic Information

Sex
Male
Female
Age, N
Mean (SD)
BMI, N
Mean (SD)
Smoking status
Never
Current
Former
Unknown
Race
White
Black
Asian
Other

Opioid
Nonusers

Acute
Opioid Users

Chronic
Opioid Users

(N ¼ 92)

(N ¼ 65)

(N ¼ 27)

51 (55%)
41 (45%)
92
60.2 (9.07)
92
30.0 (4.94)

38 (58%)
27 (42%)
65
57.0 (8.87)
65
32.4 (6.02)

10 (37%)
17 (63%)
27
58.6 (7.24)
27
32.6 (6.62)

.1557

51 (55%)
10 (11%)
28 (30%)
3 (3%)

24 (37%)
11 (17%)
26 (40%)
4 (6%)

7 (26%)
3 (11%)
14 (52%)
3 (11%)

.0651

61 (66%)
18 (20%)
3 (3%)
10 (11%)

36 (55%)
21 (32%)
4 (6%)
4 (6%)

11 (41%)
13 (48%)
0 (0%)
3 (11%)

.0575

P Value

.0802
.0125

NOTE. P value signiﬁcance at .05. Bold values denote statistically
signiﬁcant ﬁnding.
BMI, body mass index; SD, standard deviation.

preoperative, 6-month postoperative, and 1-year postoperative ofﬁce visits. These PROMIS assessments have
been shown to be relevant measures of rotator cuff pain
and function.36,51-54 The PROMIS CAT algorithm produces standardized T-scores based on normative U.S.
population data (mean scores of 50 and standard deviations of 10). Greater PROMIS UE scores represent
increased functional ability, greater PROMIS PI scores
represent increased pain that interferes with daily activities, and greater PROMIS D scores represent greater
levels of depression.55
Statistical Analysis
All continuous data are reported as mean  standard
deviation, whereas categorical data are reported as
counts and column percentages (N [%]). For continuous variables, analysis of variance was used to detect
differences in outcome scores among the 4 user groups.
Pairwise comparisons among the user groups were
accomplished using least-squares means. Univariate 2group comparisons between acute users and chronic
users for opioid data were analyzed using independent
2 sample t-tests for normally distributed variables and
Wilcoxon signed rank tests for non-normally distributed variables. A priori power analysis was not performed given the retrospective nature of data collection
being limited to data already present. Therefore, to
improve clarity on the validity of data, the magnitude of
change in PROMIS scores between time points and the
respective effect sizes (Cohen’s d) and 95% conﬁdence
intervals were calculated. Minimal clinically important
difference (MCID) was identiﬁed using a distributionbased method (1/2 the standard deviation), and the

percentage of patients that achieved MCID was calculated per study group and outcome measure.56 Statistical signiﬁcance was set at P < .05, and all tests were 2sided. All analyses are performed using SAS 9.4 (SAS
Institute Inc., Cary, NC).

Results
A total of 184 patients were identiﬁed within the
electronic medical record who underwent RCR between July 2017 and January 2020 and who had
completed PROMIS PI, PROMIS UE, and PROMIS D
forms preoperatively and 6 months’ postoperatively. Of
the 184 patients, 129 patients who underwent RCR also
were found to have completed PROMIS forms around
the 1-year postoperative period. Of the 184 patients, 92
were categorized as opioid nonusers, 65 as acute opioid
users, and 27 as chronic opioid users. An even distribution of male and female patients was observed, with
99 (54%) males and 85 (46%) females. Opioid nonusers had lower body mass index compared with acute
and chronic opioid users (30.0 vs 32.4 vs 32.6; P ¼
.013). Other demographic ﬁndings were not statistically
signiﬁcant (Table 1). When we compared the prescription data, chronic opioid users had a signiﬁcantly
greater number of prescriptions written, number of
days prescribed, and number of prescribers during the
3-month preoperative period (Table 2).
PROMIS scores were collected at similar time intervals (preoperative, 6-month, 1-year) across the 3
groups (Table 3). Table 4 compares preoperative and
postoperative PROMIS scores between opioid users.
Preoperative function (PROMIS UE) was observed to be
the lowest in chronic opioid users and highest in nonusers (P < .001). Interference in daily activities attributed to pain preoperatively (PROMIS PI) was found to
be the highest in chronic opioid users and lowest in
nonusers (P < .001). At the 6-month postoperative
timepoint, nonusers displayed signiﬁcantly superior
PROMIS UE, PROMIS PI, and PROMIS D scores
compared with opioid users (P < .05). Moreover,
chronic users failed to improve in the PROMIS D
domain 6 months after surgery. At 1-year postoperatively, signiﬁcantly superior scores across all
PROMIS measures were observed in nonusers
compared to chronic users (Table 4).
The magnitude of change in PROMIS scores between
preoperative and postoperative time points are illustrated in Figure 1. The 95% conﬁdence intervals of the
effect sizes are demonstrated in Figure 2. At 6 months
postoperatively, opioid nonusers, compared with
chronic opioid users, experienced a signiﬁcantly greater
magnitude of improvement in PROMIS D (e5.9 vs 0.0;
P < .01), but only approached signiﬁcance in PROMIS
PI and UE scores (P < .07). Moreover, at the 1-year
postoperative mark, there was no signiﬁcant difference between the magnitudes of change in the PROMIS
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Table 2. Narcotic Prescription Data
Acute
Chronic
Opioid Users Opioid Users
Number of days prescribed in
3-month period
Daily dose in MME
Number of prescriptions in 3month preoperative
period
Number of prescriptions in 1month preoperative
period
Number of prescribers in 3month preoperative
period
Number of prescribers in 1month preoperative
period

(N ¼ 65)
10.6  7.6

(N ¼ 27)
P Value
76.2  38.1 <.001

23.8  14.8
1.4  0.7

26.0  20.5
3.6  1.8

.618
<.001

0.4  0.6

1.3  1.0

<.001

1.2  0.5

1.7  0.9

.009

0.4  0.5

0.9  0.7

.002

NOTE. P value signiﬁcance at .05. Bold values denote statistically
signiﬁcant ﬁnding.
MME, morphine milliequivalent.

UE scores relative to preoperative scores among the
three study groups (Fig 1). However, the magnitude of
improvement in PROMIS PI scores between non-users
and chronic users at 1 year was signiﬁcantly greater,
as was the improvement in PROMIS D scores between
nonusers and acute users. When looking at the percentage of patients that achieved MCID at ﬁnal followup, 78%, 80%, and 47% of nonusers achieved MCID
for PROMIS UE, PI and D, respectively. In comparison,
achievement of MCID was similar for acute users (79%,
85%, 39%, respectively), but lower for chronic users
(67%, 50%, 28%, respectively).

Discussion
In the current study of patients undergoing arthroscopic RCRs, the results demonstrate that patients who
did not use opioids preoperatively reported signiﬁcantly
greater function and reduced pain and depression
scores at 6-months and 1-year postoperatively

compared with chronic users. It is also important to
note that both acute and chronic opioid users began at
lower preoperative function scores and greater pain
interference scores than nonusers.
Chronic opioid use in this study is associated with
lower functional scores and higher pain interference
scores. This is true for the 6-month and 1-year time
points. These results echo previous ﬁndings in various
orthopaedic literature such as lumbar spine surgery,
knee surgery, hip arthroplasty, and even shoulder
arthroscopy.57-60 In a similar, prospectively collected
data review, Morris et al.61 found that patients
requiring preoperative opioids demonstrated signiﬁcantly lower preoperative baseline and ﬁnal patientreported outcome scores after anatomic total shoulder
arthroplasty. Williams et al.62 demonstrated that patients undergoing arthroscopic RCR who received preoperative opioids had inferior preoperative and
postoperative patient-reported outcomes scores, similar
to the present investigation. However, both of these
studies relied on patient self-reporting “yes or no” to
preoperative opioid use, rather than quantifying the
amount and duration of preoperative opioid use based
on PDMP prescription data. Therefore, the data analysis
in the current study further strengthens previous ﬁndings that preoperative opioid use can negatively inﬂuence levels of pain and function postoperatively.
This study also demonstrated that opioid nonusers
had signiﬁcantly greater magnitude of improvement in
functional scores (PROMIS UE) compared with acute
opioid users, but this difference is not found at 1 year.
This in part may be due to patient attrition and lack of
statistical power. This is depicted by the ﬁnding that the
majority of the 95% conﬁdence intervals of the effect
sizes highlighted in Figure 2 include zero and are relatively wide for the 1-year ﬁndings, speciﬁcally for
PROMIS UE. Although some of these results may not be
statistically robust, they parallel similar ﬁndings, from a
study using validated shoulder-centric outcome scores
in patients who underwent arthroscopic RCR, by Williams et al. They found that patients without

Table 3. Administration of PROMIS Assessments: Days from Surgery
Administration of preoperative PROMIS assessment
N
Mean days (SD)
Administration of 6-month postoperative PROMIS assessments
N
Mean days (SD)
Administration of 1-year postoperative PROMIS assessments
N
Mean days (SD)

Nonuser

Acute User

Chronic User

P Value

92
e42 (44.92)

65
e41 (45.87)

27
e50 (60.98)

.57

92
165 (46.14)

65
149 (60.01)

27
152 (54.1)

.17

69
675 (356.7)

42
601 (296.6)

18
523 (314.5)

.07

NOTE. P value signiﬁcance at .05. Bold values denote statistically signiﬁcant ﬁnding.
PROMIS, Patient-Reported Outcomes Measurement Information System; SD, standard deviation.
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Table 4. PROMIS Data Comparison Among Opioid User Groups

Acute User

Chronics User

ANOVA
P Value

Nonuser vs Acute User

Nonuser vs Chronic User

Acute User vs Chronic User

92
30.6 (5.57)
e

65
28.8 (5.43)
e

27
26.1 (5.28)
e

e
.0001
e

e
.0389
e0.33 (e0.65, e0.01)

e
.0002
e0.83 (e1.27, e0.39)

e
.0314
e0.50 (e0.96, e0.05)

92
61.5 (4.56)
e

65
64.9 (5.30)
e

27
65.3 (4.98)
e

e
<.0001
e

e
<.0001
0.69 (0.36-1.01)

e
.0005
0.80 (0.36-1.24)

e
.6875
0.08 (e0.37 0.53)

92
47.6 (7.67)
e

65
49.2 (10.46)
e

27
51.1 (10.03)
e

e
.0695
e

e
.2921
0.17 (e0.14, 0.49)

e
.0836
0.39 (e0.04, 0.82)

e
.3611
0.19 (e0.26, 0.63)

92
41.7 (9.58)
e

65
35.6 (9.39)
e

27
33.5 (7.48)
e

e
<.0001
e

e
<.0001
e0.64 (e0.97, e0.32)

e
<.0001
e0.95 (e1.40, e0.51)

e
.3222
e0.25 (e0.70, 0.20)

91
50.7 (8.77)
e

64
56.3 (8.48)
e

27
58.1 (7.99)
e

e
<.0001
e

e
<.0001
0.65 (0.32-0.98)

e
.0001
0.88 (0.44-1.33)

e
.3649
0.22 (e0.23, 0.67)

90
41.6 (8.35)
e

64
45.8 (10.88)
e

27
51.1 (10.70)
e

e
<.0001
e

e
.008
0.43 (0.11-0.76)

e
<.0001
0.99 (0.54-1.44)

e
.0182
0.49 (0.04-0.95)

69
45.3 (11.66)
e

42
41.9 (11.05)
e

18
37.4 (8.89)
e

e
.0056
e

e
.1214
e0.30 (e0.68, 0.09)

e
.0081
e0.76 (e1.29, e0.23)

e
.1516
e0.45 (e1.01, 0.11)

69
47.9 (9.02)
e

39
54.3 (10.34)
e

18
57.4 (8.18)
e

e
<.0001
e

e
.0008
0.66 (0.26-1.06)

e
.0002
1.1 (0.56-1.65)

e
.2471
0.33 (e0.23, 0.89)

68
41.6 (8.08)

39
48.3 (11.29)

18
49.2 (11.02)

e
.0002

e
.0007
0.68 (0.28-1.09)

e
.0033
0.79 (0.25-1.32)

e
.7394
0.08 (e0.48, 0.64)
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Preoperative PROMIS UE
N
Mean (SD)
Effect Size (d) (95% CI)
Preoperative PROMIS PI
N
Mean (SD)
Effect Size (d) (95% CI)
Preoperative PROMIS D
N
Mean (SD)
Effect Size (d) (95% CI)
6-month PROMIS UE
N
Mean (SD)
Effect Size (d) (95% CI)
6-month PROMIS PI
N
Mean (SD)
Effect Size (d) (95% CI)
6 Month PROMIS D
N
Mean (SD)
Effect Size (d) (95% CI)
1-year PROMIS UE
N
Mean (SD)
Effect Size (d) (95% CI)
1-year PROMIS PI
N
Mean (SD)
Effect Size (d) (95% CI)
1-year PROMIS D
N
Mean (SD)
Effect Size (d) (95% CI)

Pairwise Comparison P Value

Nonuser

NOTE. P value signiﬁcance at .05. Bold values denote statistically signiﬁcant ﬁnding.
ANOVA, analysis of variance; CI, conﬁdence interval; D, Depression; PI, Pain Interference; PROMIS, Patient-Reported Outcomes Measurement Information System; SD, standard deviation;
UE, Upper Extremity.
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Fig 1. Changes in postoperative PROMIS scores compared with preoperative levels. *Denotes signiﬁcant difference. (D,
Depression; PI, Pain Interference; PROMIS, Patient-Reported Outcome Measurement Information System; UE, Upper
Extremity.).

preoperative opioid use had no difference in magnitude
of improvement in American Shoulder and Elbow
Surgeons (37.9 vs 36.4; P ¼ .351), Constant (26.7 vs
31.8; P¼ .350), and Simple Shoulder Test (4.1 vs 3.5;
P ¼ .06) to patients with preoperative opioid use,
respectively.62 The main difference here being is that
the current study employed the use of PROMIS scores
to track patient-reported outcomes compared with
more traditionally used shoulder-centric scores used in
the aforementioned studies. The literature has shown
that PROMIS questionnaires are quicker to administer,
with a lower question burden, and have favorable
psychometric properties in rotator cuff patients.54,63
In concert with these previous investigations, the
current study’s ﬁndings indicate that opioid use preoperatively may delay improvement of functional outcomes, as the magnitude of improvement in functional
outcomes among opioid users appeared to lag behind
those of nonusers at 6 months postoperatively, before
reaching a similar level of improvement in the longterm. The timing of improvement may be of paramount importance. As the majority of postoperative
rehabilitation following rotator cuff repair occurs during the ﬁrst 6 months postoperatively, and the gains
from physical therapy and rehabilitation may be intimately related to the patient’s ability to adhere to the
rehabilitation regimen and tolerance of exercises. These

data illustrate a signiﬁcantly greater magnitude of
improvement within the ﬁrst 6 months in nonusers,
and that there is a potential delay in improvement
among opioid users. This might inﬂuence clinicians to
identify which patients may require prolonged physical
therapy or an adjusted regimen to account for this
delay. In addition, opioid nonusers reported superior
outcome scores across all time points, so while the
magnitude of improvement was similar, the start and
end points were superior among non-users.
The clinical relevance of the observed improvement
in patient-reported outcomes is important to consider.
Currently, there is a lack of published MCID values for
PROMIS UE, PROMIS PI, and PROMIS D in rotator cuff
patients. Using the distribution-based method for
determining MCID, a contemporary systematic review
proposes that half of the standard deviation often
accurately estimates the threshold of discrimination for
appreciable change when assessing health related
quality of life.56 Although simplistic, this method suggests that a change of 5 points or more in PROMIS
scores is meaningful given the standardized scoring
system of 50-point means, and 10-point standard deviations. Previous studies have used this method to
estimate MCID in arthroplasty and carpal tunnel patients.39,55,64 By these standards, nonusers and acute
opioid users achieved MCID at similar rates, but chronic
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Fig 2. Magnitude of change in PROMIS scores: pairwise comparison effect sizes, 95% conﬁdence intervals. (D, Depression; PI,
Pain Interference; PROMIS, Patient-Reported Outcome Measurement Information System; UE, Upper Extremity.).

opioid users achieved MCID at a lower rate as depicted
in the results section. Given the nature of cuff tears,
most of which are chronic and often not indicated for
surgery until after conservative measures are exhausted,65 these ﬁndings inherently carry implications for
many patients who live in pain for prolonged periods
preoperatively. Patients undergoing conservative
treatments who rely on opioids for adequate pain
control in order to sufﬁciently complete these rehabilitative protocols present a target population that may
beneﬁt most from alternative pain regimens. The results
of this study imply that opioid analgesia, perhaps during
nonoperative treatment of RCTs, may associate with a
delay in improvement in the early postoperative period
following operative intervention.
Pain scores and functional scores following surgical
RCR have been well-documented in the literature,
however the role of depression scores is an evolving
area of study. Cho et al.66 have demonstrated that 26%
of patients scheduled to undergo RCR experience
depression. However, that particular study did not
delineate the role of opioid use as a contributing factor.
Studies have shown the limbic system to be one of a
few locations in the brain that is rich in opioid receptors.67 This same area is highly involved in mood
regulation as well. Furthermore, opioid misuse in patients with depressive symptoms has been shown to
increase risk in developing major depressive disorder.68,69 Therefore, opioid use must be looked at as a
serious player in the role of depressed mood in the
orthopaedic patient. At both 6 months and 1 year after
RCR, chronic preoperative opioid use was associated

with signiﬁcantly worse PROMIS D scores in the present study. Furthermore, acute users had signiﬁcantly
less improvement in PROMIS D compared with nonusers at 6 months. Meanwhile, chronic users had
signiﬁcantly less improvement compared to nonusers at
1 year. These ﬁndings are supported by a previous
investigation from Kazmers et al.,70 showing that hand
clinic patients with a history of baseline opioid use
demonstrated signiﬁcantly worse scores on all patientreported outcomes, and a signiﬁcantly greater proportion of patients with PROMIS D scores exceeding 60 (1
SD above the mean). However, their study relied on
patients self-reporting their opioid use and did not
attempt to quantify amount or duration of opioid use.
Meanwhile studies in RCR populations have shown that
patients with preoperative opioid use are more likely to
be associated with a comorbid diagnosis of depression/
anxiety or are taking antidepressants/anxiolytics at
greater proportions.48,62 Yet, there is limited literature
that describes the relationship between preoperative
opioid use and mood speciﬁc scores in patients undergoing RCR, like the current study does. Therefore,
additional prospective investigation is required to further
delineate the interrelationship between opioid use and
depressive mood as it pertains to the degree of inﬂuence
on outcomes following rotator cuff repair.
Tracking opioid use in patients accurately can be
challenging. This study employed the use of a statewide PDMP to monitor prescription ﬁlling as a surrogate for patient opioid use, as used in prior
studies.19,20,24,71,72 These databases have been shown
to be accurate in terms of tracking prescription ﬁlling.73
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In the current study, aside from an equivalent daily
MME dose, chronic opioid users had signiﬁcantly more
days prescribed, prescribers, and prescriptions ﬁlled
when compared to acute users. This demonstrates a
distinct difference between these two samples of patients further supporting the criteria used to group our
study population that is also in line with the deﬁnition
provided by the Centers for Disease Control and Prevention for chronic opioid use (i.e., usage most days for
at least 3 months).74 In addition, the similar daily MME
dose data, but signiﬁcantly different days prescribed and
prescriptions ﬁlled data between the opioid use groups
demonstrates that perhaps it is the chronicity of opioid
use, rather than the amount taken, that is most inﬂuential in patient outcomes.
Limitations
This study is not without limitations. Primarily, opioid
usage was determined using a statewide PDMP. This
online platform tracks prescriptions as they are ﬁlled;
however, it cannot be conﬁrmed whether a patient is
taking the medication as prescribed. Although pain diaries have been used for accurate medication tracking
in previous studies, that still relies on self-reporting,
which can be inaccurate as well.75 Although arbitrary,
the categorization of opioid users in the current study
had signiﬁcant differences in opioid use longevity and
produced detectable differences in pain and function
scores. Furthermore, the chronic user group displayed a
number of days prescribed that was more than half of
the days within the 3-month window, which is in line
with guidelines from the Centers for Disease Control
and Prevention for chronic opioid use.74 We did not
collect postoperative opioid data, as this was not within
the objective for the study, but can represent a confounding factor present in the study. In addition, not all
postoperative patients followed up at 1 year (129/184,
70.1%). Although this is a sizeable loss, previous
research has shown that 6 months is adequate time for
PROMIS CAT forms to be sensitive to clinical change.36
Finally, potentially confounding RCT characteristics
were not collected. The current study did not stratify or
subcategorize opioid users based on RCT characteristics
such as tear size, tendon retraction, number of tendons
involved, or whether certain procedures also were
performed in addition to RCR such as biceps tenotomy/
tenodesis. Some of these factors have been shown to be
contributors to pain and dysfunction postoperatively.76,77 However, there is research to indicate
that psychosocial factors may play a greater role in
postoperative pain than do structural characteristics of
the cuff tear itself.78 There is also some merit in
including a heterogenous sample of rotator cuff pathology and repairs, as it makes the current ﬁndings
more generalizable when counseling patients about
opioid use before RCR.

Conclusions
Patients undergoing RCR demonstrated superior
PROMIS scores pre- and postoperatively if they did not
use opioids within 3 months before surgery.
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